Colleen E Kovacsics1, Alexander J Gill1, Surendra S Ambegaokar2, Benjamin B Gelman3, Dennis L Kolson1. 1. Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104. 2. Department of Botany & Microbiology, Robbins Program in Neuroscience, Ohio Wesleyan University, Delaware, Ohio, 43015. 3. Department of Pathology, University of Texas Medical Branch, Galveston, Texas, 77555.
Abstract
Induction of the detoxifying enzyme heme oxygenase-1 (HO-1) is a critical protective host response to cellular injury associated with inflammation and oxidative stress. We previously found that HO-1 protein expression is reduced in brains of HIV-infected individuals with HIV-associated neurocognitive disorders (HAND) and in HIV-infected macrophages, where this reduction associates with enhanced glutamate release and neurotoxicity. Because HIV-infected macrophages are a small component of the cellular content of the brain, the reduction of macrophage HO-1 expression likely accounts for a small portion of brain HO-1 loss in HIV infection. We therefore investigated the contribution of astrocytes, the major pool of brain HO-1. We identified immunoproteasome-mediated HO-1 degradation in astrocytes as a second possible mechanism of brain HO-1 loss in HIV infection. We demonstrate that prolonged exposure of human fetal astrocytes to interferon-gamma (IFNγ), an HIV-associated CNS immune activator, selectively reduces expression of HO-1 protein without a concomitant reduction in HO-1 RNA, increases expression of immunoproteasome subunits, and decreases expression of constitutive proteasome subunits, consistent with a shift towards increased immunoproteasome activity. In HIV-infected brain HO-1 protein reduction also associates with increased HO-1 RNA expression and increased immunoproteasome expression. Finally, we show that IFNγ treatment of astrocytic cells reduces HO-1 protein half-life in a proteasome-dependent manner. Our data thus suggest unique causal links among HIV infection, IFNγ-mediated immunoproteasome induction, and enhanced HO-1 degradation, which likely contribute to neurocognitive impairment in HAND. Such IFNγ-mediated HO-1 degradation should be further investigated for a role in neurodegeneration in inflammatory brain conditions. BRIEF SUMMARY: Kovacsics et al. identify immunoproteasome degradation of heme oxygenase-1 (HO-1) in interferon gamma-stimulated astrocytes as a plausible mechanism for the observed loss of HO-1 protein expression in the brains of HIV-infected individuals, which likely contributes to the neurocognitive impairment in HIV-associated neurocognitive disorders.
Induction of the detoxifying enzyme heme oxygenase-1 (HO-1) is a critical protective host response to cellular injury associated with inflammation and oxidative stress. We previously found that HO-1 protein expression is reduced in brains of HIV-infected individuals with HIV-associated neurocognitive disorders (HAND) and in HIV-infected macrophages, where this reduction associates with enhanced glutamate release and neurotoxicity. Because HIV-infected macrophages are a small component of the cellular content of the brain, the reduction of macrophage HO-1 expression likely accounts for a small portion of brain HO-1 loss in HIV infection. We therefore investigated the contribution of astrocytes, the major pool of brain HO-1. We identified immunoproteasome-mediated HO-1 degradation in astrocytes as a second possible mechanism of brain HO-1 loss in HIV infection. We demonstrate that prolonged exposure of human fetal astrocytes to interferon-gamma (IFNγ), an HIV-associated CNS immune activator, selectively reduces expression of HO-1 protein without a concomitant reduction in HO-1 RNA, increases expression of immunoproteasome subunits, and decreases expression of constitutive proteasome subunits, consistent with a shift towards increased immunoproteasome activity. In HIV-infected brain HO-1 protein reduction also associates with increased HO-1 RNA expression and increased immunoproteasome expression. Finally, we show that IFNγ treatment of astrocytic cells reduces HO-1 protein half-life in a proteasome-dependent manner. Our data thus suggest unique causal links among HIV infection, IFNγ-mediated immunoproteasome induction, and enhanced HO-1 degradation, which likely contribute to neurocognitive impairment in HAND. Such IFNγ-mediated HO-1 degradation should be further investigated for a role in neurodegeneration in inflammatory brain conditions. BRIEF SUMMARY: Kovacsics et al. identify immunoproteasome degradation of heme oxygenase-1 (HO-1) in interferon gamma-stimulated astrocytes as a plausible mechanism for the observed loss of HO-1 protein expression in the brains of HIV-infected individuals, which likely contributes to the neurocognitive impairment in HIV-associated neurocognitive disorders.
Authors: E S Kuzina; E L Chernolovskaya; A A Kudriaeva; M A Zenkova; V D Knorre; E A Surina; N A Ponomarenko; T V Bobik; I V Smirnov; A V Bacheva; A A Belogurov; A G Gabibov; V V Vlasov Journal: Dokl Biochem Biophys Date: 2014-01-03 Impact factor: 0.788
Authors: M Aki; N Shimbara; M Takashina; K Akiyama; S Kagawa; T Tamura; N Tanahashi; T Yoshimura; K Tanaka; A Ichihara Journal: J Biochem Date: 1994-02 Impact factor: 3.387
Authors: Alexander J Gill; Colleen E Kovacsics; Stephanie A Cross; Patricia J Vance; Lorraine L Kolson; Kelly L Jordan-Sciutto; Benjamin B Gelman; Dennis L Kolson Journal: J Clin Invest Date: 2014-09-09 Impact factor: 14.808
Authors: Alexander J Gill; Rolando Garza; Surendra S Ambegaokar; Benjamin B Gelman; Dennis L Kolson Journal: J Neuroinflammation Date: 2018-03-06 Impact factor: 8.322
Authors: Rolando Garza; Alexander J Gill; Brandon L Bastien; Yoelvis Garcia-Mesa; Analise L Gruenewald; Benjamin B Gelman; Billy Tsima; Robert Gross; Scott L Letendre; Dennis L Kolson Journal: Neurol Neuroimmunol Neuroinflamm Date: 2020-04-10
Authors: Analise L Gruenewald; Yoelvis Garcia-Mesa; Alexander J Gill; Rolando Garza; Benjamin B Gelman; Dennis L Kolson Journal: J Neurovirol Date: 2020-09-10 Impact factor: 2.643
Authors: Daniel Ojeda-Juárez; Rohan Shah; Jerel Adam Fields; Indira S Harahap-Carrillo; Jeffrey Koury; Ricky Maung; Benjamin B Gelman; Bas J Baaten; Amanda J Roberts; Marcus Kaul Journal: Brain Behav Immun Date: 2020-06-11 Impact factor: 7.217